KROS   $56.75  -0.99% Market Open

Keros Therapeutics Inc
Total Cash 405.86M
totalCashPerShare 10.817
EBITDA -187.62M
Total Debt 13.96M
quickRatio 19.167
currentRatio 20.368
Total Revenue 271.00K
debtToEquity 3.316
Revenue/Share 0.008
ROA -0.29066
ROE -0.44984
grossProfits
freeCashflow -96.84M
operatingCashflow -143.80M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -1363.2163
profitMargins 0.0
enterpriseValue 1.75B
forwardPE -10.623106
floatShares 32.39M
sharesOutstanding 37.52M
sharesShort 3.41M
sharesShortPriorMonth 3.17M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.99%
Short Ratio help_outline 12.63%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 11.637
Price To Book help_outline 4.82
earningsQuarterlyGrowth
netIncomeToCommon -168.05M
trailingEps -5.13%
forwardEps -5.28%
enterpriseToEbitda -9.31
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.27 3Q 2024
institutionsCount 222
lastUpdated Sept. 16, 2024, 7:52 p.m.